Samsara Biocapital, L.p. - Net Worth and Insider Trading

Samsara Biocapital, L.p. Net Worth

The estimated net worth of Samsara Biocapital, L.p. is at least $27 Million dollars as of 2024-04-25. Samsara Biocapital, L.p. is the 10% Owner of Graphite Bio Inc and owns about 8,497,067 shares of Graphite Bio Inc (GRPH) stock worth over $27 Million. Details can be seen in Samsara Biocapital, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Samsara Biocapital, L.p. has not made any transactions after 2022-04-12 and currently still holds the listed stock(s).

Transaction Summary of Samsara Biocapital, L.p.

To

Samsara Biocapital, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samsara Biocapital, L.p. owns 3 companies in total, including Graphite Bio Inc () , Mineralys Therapeutics Inc () , and Scholar Rock Holding Corp () .

Click here to see the complete history of Samsara Biocapital, L.p.’s form 4 insider trades.

Insider Ownership Summary of Samsara Biocapital, L.p.

Ticker Comapny Transaction Date Type of Owner
Graphite Bio Inc 2022-04-12 10 percent owner
Mineralys Therapeutics Inc 2023-02-09 10 percent owner
Scholar Rock Holding Corp 2022-06-22 10 percent owner

Samsara Biocapital, L.p. Latest Holdings Summary

Samsara Biocapital, L.p. currently owns a total of 1 stock. Samsara Biocapital, L.p. owns 8,497,067 shares of Graphite Bio Inc (GRPH) as of April 12, 2022, with a value of $27 Million.

Latest Holdings of Samsara Biocapital, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GRPH Graphite Bio Inc 2022-04-12 8,497,067 3.18 27,020,673

Holding Weightings of Samsara Biocapital, L.p.


Samsara Biocapital, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Samsara Biocapital, L.p. has made a total of 7 transactions in Graphite Bio Inc (GRPH) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Graphite Bio Inc is the acquisition of 424,464 shares on April 12, 2022, which cost Samsara Biocapital, L.p. around $2 Million.

Insider Trading History of Samsara Biocapital, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Samsara Biocapital, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Samsara Biocapital, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Samsara Biocapital, L.p. is -28.42%. GuruFocus also compares Samsara Biocapital, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Samsara Biocapital, L.p. within 3 months outperforms 1 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Samsara Biocapital, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Samsara Biocapital, L.p.

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -5.06 -28.42 -62.64 -68.84 -51.22
Relative Return to S&P 500(%) -4.31 -25.05 -51.74 -55.12 -52.08

Samsara Biocapital, L.p. Ownership Network

Ownership Network List of Samsara Biocapital, L.p.

No Data

Ownership Network Relation of Samsara Biocapital, L.p.


Samsara Biocapital, L.p. Owned Company Details

What does Graphite Bio Inc do?

Who are the key executives at Graphite Bio Inc?

Samsara Biocapital, L.p. is the 10 percent owner of Graphite Bio Inc. Other key executives at Graphite Bio Inc include 10 percent owner Ecor1 Capital, Llc , CHIEF BUSINESS OFFICER Phil Gutry , and Chief Financial Officer Alethia Young .

Graphite Bio Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Graphite Bio Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Graphite Bio Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Graphite Bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Graphite Bio Inc Insider Transactions

No Available Data

Samsara Biocapital, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Samsara Biocapital, L.p.. You might contact Samsara Biocapital, L.p. via mailing address: 628 Middlefield Road, Palo Alto Ca 94301.

Discussions on Samsara Biocapital, L.p.

No discussions yet.